Therapeutic Strategies and Genetic Implications for Periodontal Disease Management: A Systematic Review.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
29 Jun 2024
Historique:
received: 01 06 2024
revised: 23 06 2024
accepted: 28 06 2024
medline: 13 7 2024
pubmed: 13 7 2024
entrez: 13 7 2024
Statut: epublish

Résumé

The objective of this review is to identify the microbiological alterations caused by various therapy modalities by critically analyzing the current findings. We limited our search to English-language papers published between 1 January 2004 and 7 May 2024 in PubMed, Scopus, and Web of Science that were relevant to our topic. In the search approach, the Boolean keywords "microbio*" AND "periodontitis" were used. A total of 5152 papers were obtained from the databases Web of Science (2205), PubMed (1793), and Scopus (1154). This resulted in 3266 articles after eliminating duplicates (1886), and 1411 entries were eliminated after their titles and abstracts were examined. The qualitative analysis of the 22 final articles is included in this study. Research on periodontal disease shows that periodontitis alters the oral microbiome and increases antibiotic resistance. Treatments like scaling and root planing (SRP), especially when combined with minocycline, improve clinical outcomes by reducing harmful bacteria. Comprehensive mechanical debridement with antibiotics, probiotics, EMD with bone grafts, and other adjunctive therapies enhances periodontal health. Personalized treatment strategies and advanced microbial analyses are crucial for effective periodontal management and antibiotic resistance control.

Identifiants

pubmed: 39000324
pii: ijms25137217
doi: 10.3390/ijms25137217
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Systematic Review Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Alessandra Laforgia (A)

Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.

Alessio Danilo Inchingolo (AD)

Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.

Fabio Piras (F)

Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.

Valeria Colonna (V)

Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.

Roberto Vito Giorgio (RV)

Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.

Claudio Carone (C)

Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.

Biagio Rapone (B)

Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.

Giuseppina Malcangi (G)

Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.

Angelo Michele Inchingolo (AM)

Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.

Francesco Inchingolo (F)

Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.

Andrea Palermo (A)

College of Medicine and Dentistry, CoMD Birmingham Campus, Birmingham B4 6BN, UK.

Gianna Dipalma (G)

Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH